Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:associatedWith |
splenomegaly
cytopenias |
| gptkbp:blastPercentageInBlood |
>5% and <20%
|
| gptkbp:blastPercentageInBoneMarrow |
>10% and <20%
|
| gptkbp:canProgressTo |
gptkb:acute_myeloid_leukemia
|
| gptkbp:characterizedBy |
increased blast cells in blood or bone marrow
|
| gptkbp:definedIn |
gptkb:WHO_classification
|
| gptkbp:diagnosedBy |
gptkb:blood_test
bone marrow biopsy |
| gptkbp:firstDescribed |
2008 WHO classification
|
| gptkbp:prognosis |
worse than CMML-1
|
| gptkbp:subspecies |
gptkb:chronic_myelomonocytic_leukemia
|
| gptkbp:treatment |
chemotherapy
stem cell transplantation hypomethylating agents |
| gptkbp:bfsParent |
gptkb:chronic_myelomonocytic_leukemia
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
CMML-2
|